Van Eck Associates Corp Bristol Myers Squibb CO Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Eck Associates Corp holds 9,933,591 shares of BMY stock, worth $572 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

9,933,591

Previous 9,152,206 8.54%

Holding current value

$572 Million

Previous $380 Million 38.67%

% of portfolio

0.66%

Previous 0.54%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$39.66 - $51.75 $31 Million - $40.4 Million	781,385 Added 8.54%	9,933,591 $527 Million
Q2 2024 Jul 31, 2024	BUY	$40.25 - $52.99 $48.4 Million - $63.7 Million	1,203,033 Added 15.13%	9,152,206 $380 Million
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $188 Million - $213 Million	3,918,234 Added 97.2%	7,949,173 $431 Million
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $174 Million - $207 Million	3,579,324 Added 792.56%	4,030,939 $207 Million
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $4.84 Million - $5.41 Million	83,599 Added 22.72%	451,615 $26.2 Million
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $1.74 Million - $1.93 Million	27,244 Added 7.99%	368,016 $23.5 Million
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $9.53 Million - $10.8 Million	-145,080 Reduced 29.86%	340,772 $23.6 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $1.83 Million - $2.16 Million	-26,657 Reduced 5.2%	485,852 $35 Million
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $2,375 - $1.4 Million	18,270 Added 3.7%	512,509 $36.4 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $97.5 Million - $107 Million	-1,343,021 Reduced 73.1%	494,239 $38.1 Million
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $94.1 Million - $113 Million	-1,530,832 Reduced 45.45%	1,837,260 $134 Million
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $14.3 Million - $16.7 Million	267,069 Added 8.61%	3,368,092 $210 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $18.8 Million - $22 Million	317,524 Added 11.41%	3,101,023 $183 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $25.7 Million - $28 Million	415,920 Added 17.57%	2,783,499 $186 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $23.3 Million - $26.2 Million	392,331 Added 19.86%	2,367,579 $149 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $8.58 Million - $9.72 Million	148,632 Added 8.14%	1,975,248 $123 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $44.6 Million - $49.4 Million	776,505 Added 73.95%	1,826,616 $110 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $2.02 Million - $2.37 Million	36,906 Added 3.64%	1,050,111 $61.7 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $38.5 Million - $56 Million	-830,010 Reduced 45.03%	1,013,205 $56.5 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $13.5 Million - $17.7 Million	275,262 Added 17.56%	1,843,215 $118 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $29.3 Million - $34.8 Million	685,314 Added 77.64%	1,567,953 $79.5 Million
Q2 2019 Aug 07, 2019	BUY	$44.62 - $49.34 $6.91 Million - $7.64 Million	154,830 Added 21.27%	882,639 $40 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $1.62 Million - $1.93 Million	35,945 Added 5.2%	727,809 $34.7 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $2.22 Million - $2.88 Million	45,599 Added 7.06%	691,864 $36 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $967,756 - $1.09 Million	-17,535 Reduced 2.64%	646,265 $40.1 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $10.2 Million - $12.7 Million	201,430 Added 43.56%	663,800 $36.7 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $17.5 Million - $20.1 Million	-291,488 Reduced 38.67%	462,370 $29.2 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $2.24 Million - $2.45 Million	-37,417 Reduced 4.73%	753,858 $46.2 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $301,058 - $347,446	5,451 Added 0.69%	791,275 $50.4 Million
Q2 2017 Aug 11, 2017	BUY	N/A	785,824	785,824 $43.8 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Bristol Myers Squibb CO Transaction History